Skip to content

Clinical trials

Terminated Leukemia, Myeloid, Acute trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Terminated Country / region: Germany Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20081
20093
20101
20112
20121
20131
20143
20155
20166
20174
20184
20196
20205
20215
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Technische Universität Dresden5
AbbVie4
Amgen4
Novartis Pharmaceuticals4
University of Ulm4
Gilead Sciences3
AvenCell Europe GmbH2
University Hospital Carl Gustav Carus2
University Hospital Heidelberg2
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute56
Myelodysplastic Syndromes9
Recurrence7
Neoplasms4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia2
Leukemia, Myelomonocytic, Chronic2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.